ELTX
Elicio Therapeutics, Inc.$3.03-0.09 (-2.89%)Prev Close$3.11·MCap$77.9M·P/E—·Vol659.5K·Yield—
▲
Buys (12M)
0
$0.00
▼
Sells (12M)
0
$0.00
◆
Net Activity
Net Buyer
$0.00
●
Active Insiders
0
last 12 mo
ELTX Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Nov 26, 2024 | Venkatesan Jay | Director | Sell | 50,000 | $0.01 | $500.00 | 179,581 |
| Dec 22, 2023 | Chudnovsky Yekaterina | Director | Buy | 1,213,000 | $5.81 | $7.05M6.6% OS | 1,915,639+173% |
| Jul 1, 2022 | Goldberg Itzhak | Director | Sell | 32,082 | $1.12 | $35.9K | 1,687,986 |
| May 25, 2022 | Venkatesan Jay | See Remarks | Buy | 11,313 | $1.25 | $14.1K | 1,891,947 |
| May 20, 2022 | Venkatesan Jay | See Remarks | Buy | 82,200 | $1.23 | $101.4K | 1,721,457 |
| May 19, 2022 | Nissenson Allen | Director | Buy | 9,383 | $1.16 | $10.9K | 9,383 |
| Dec 27, 2021 | Venkatesan Jay | See Remarks | Buy | 277,244 | $2.63 | $730.4K1.5% OS | 1,639,257 |
| Dec 20, 2021 | Neylan John F. | See Remarks | Sell | 358 | $2.62 | $938.00 | 35,136 |
| Dec 20, 2021 | Venkatesan Jay | See Remarks | Buy | 3,527 | $2.54 | $9.0K | 1,362,013 |
| Dec 16, 2021 | Venkatesan Jay | See Remarks | Buy | 41,625 | $2.55 | $106.0K | 1,358,486 |
| Dec 15, 2021 | CURHAN GREGORY S | See Remarks | Buy | 4,000 | $2.37 | $9.5K | 4,000 |
| Dec 14, 2021 | Rhodes Jennifer J | See Remarks | Sell | 451 | $2.42 | $1.1K | 30,399 |
| Dec 6, 2021 | Goldberg Itzhak | See Remarks | Sell | 32,118 | $3.35 | $107.7K | 1,720,068 |
| Dec 1, 2021 | Goldberg Itzhak | See Remarks | Sell | 117,882 | $3.48 | $410.2K0.6% OS | 1,831,201 |
| Nov 18, 2021 | Neylan John F. | See Remarks | Sell | 374 | $4.13 | $1.5K | 35,494 |
| Nov 15, 2021 | Rhodes Jennifer J | See Remarks | Sell | 433 | $4.40 | $1.9K | 30,850 |
| Oct 18, 2021 | Neylan John F. | See Remarks | Sell | 373 | $8.62 | $3.2K | 35,868 |
| Oct 14, 2021 | Rhodes Jennifer J | See Remarks | Sell | 430 | $8.65 | $3.7K | 31,283 |
| Sep 20, 2021 | Neylan John F. | See Remarks | Sell | 376 | $10.07 | $3.8K | 36,241 |
| Sep 14, 2021 | Rhodes Jennifer J | See Remarks | Sell | 430 | $10.64 | $4.6K | 31,713 |
| Aug 18, 2021 | Neylan John F. | See Remarks | Sell | 381 | $9.03 | $3.4K | 36,617 |
| Aug 16, 2021 | Rhodes Jennifer J | See Remarks | Sell | 445 | $10.68 | $4.8K | 32,143 |
| Jul 21, 2021 | Neylan John F. | See Remarks | Sell | 365 | $10.98 | $4.0K | 36,998 |
| Jul 21, 2021 | Rhodes Jennifer J | See Remarks | Sell | 432 | $10.94 | $4.7K | 32,588 |
| Jul 14, 2021 | Rhodes Jennifer J | See Remarks | Sell | 431 | $11.01 | $4.7K | 32,589 |
| Jun 24, 2021 | Goldberg Itzhak | See Remarks | Sell | 197,410 | $6.50 | $1.28M1.1% OS | 2,020,068 |
| Jun 24, 2021 | Venkatesan Jay | See Remarks | Buy | 77,604 | $2.41 | $187.0K | 1,316,861 |
| Jun 24, 2021 | Venkatesan Jay | See Remarks | Sell | 41,091 | $13.78 | $566.2K | 1,239,257 |
| Jun 18, 2021 | Neylan John F. | See Remarks | Sell | 366 | $13.20 | $4.8K | 37,363 |
| Jun 14, 2021 | Rhodes Jennifer J | See Remarks | Sell | 427 | $13.27 | $5.7K | 33,020 |
| May 18, 2021 | Neylan John F. | See Remarks | Sell | 363 | $13.91 | $5.0K | 37,729 |
| May 14, 2021 | Rhodes Jennifer J | See Remarks | Sell | 440 | $13.92 | $6.1K | 33,447 |
| Apr 19, 2021 | Neylan John F. | See Remarks | Sell | 381 | $13.55 | $5.2K | 38,092 |
| Apr 15, 2021 | Rhodes Jennifer J | See Remarks | Sell | 399 | $15.01 | $6.0K | 33,887 |
| Mar 17, 2021 | Neylan John F. | See Remarks | Sell | 442 | $19.13 | $8.5K | 38,453 |
| Mar 13, 2021 | Rhodes Jennifer J | See Remarks | Sell | 499 | $20.45 | $10.2K | 34,286 |
ELTX Insider Buying Activity
The following table shows recent insider purchases of Elicio Therapeutics, Inc. (ELTX) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Dec 22, 2023 | Chudnovsky Yekaterina | Director | Buy | 1,213,000 | $5.81 | $7.05M6.6% OS | 1,915,639+173% |
| May 25, 2022 | Venkatesan Jay | See Remarks | Buy | 11,313 | $1.25 | $14.1K | 1,891,947 |
| May 20, 2022 | Venkatesan Jay | See Remarks | Buy | 82,200 | $1.23 | $101.4K | 1,721,457 |
| May 19, 2022 | Nissenson Allen | Director | Buy | 9,383 | $1.16 | $10.9K | 9,383 |
| Dec 27, 2021 | Venkatesan Jay | See Remarks | Buy | 277,244 | $2.63 | $730.4K1.5% OS | 1,639,257 |
| Dec 20, 2021 | Venkatesan Jay | See Remarks | Buy | 3,527 | $2.54 | $9.0K | 1,362,013 |
| Dec 16, 2021 | Venkatesan Jay | See Remarks | Buy | 41,625 | $2.55 | $106.0K | 1,358,486 |
| Dec 15, 2021 | CURHAN GREGORY S | See Remarks | Buy | 4,000 | $2.37 | $9.5K | 4,000 |
| Jun 24, 2021 | Venkatesan Jay | See Remarks | Buy | 77,604 | $2.41 | $187.0K | 1,316,861 |
ELTX Insider Selling Activity
The following table shows recent insider sales of Elicio Therapeutics, Inc. (ELTX) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Nov 26, 2024 | Venkatesan Jay | Director | Sell | 50,000 | $0.01 | $500.00 | 179,581 |
| Jul 1, 2022 | Goldberg Itzhak | Director | Sell | 32,082 | $1.12 | $35.9K | 1,687,986 |
| Dec 20, 2021 | Neylan John F. | See Remarks | Sell | 358 | $2.62 | $938.00 | 35,136 |
| Dec 14, 2021 | Rhodes Jennifer J | See Remarks | Sell | 451 | $2.42 | $1.1K | 30,399 |
| Dec 6, 2021 | Goldberg Itzhak | See Remarks | Sell | 32,118 | $3.35 | $107.7K | 1,720,068 |
| Dec 1, 2021 | Goldberg Itzhak | See Remarks | Sell | 117,882 | $3.48 | $410.2K0.6% OS | 1,831,201 |
| Nov 18, 2021 | Neylan John F. | See Remarks | Sell | 374 | $4.13 | $1.5K | 35,494 |
| Nov 15, 2021 | Rhodes Jennifer J | See Remarks | Sell | 433 | $4.40 | $1.9K | 30,850 |
| Oct 18, 2021 | Neylan John F. | See Remarks | Sell | 373 | $8.62 | $3.2K | 35,868 |
| Oct 14, 2021 | Rhodes Jennifer J | See Remarks | Sell | 430 | $8.65 | $3.7K | 31,283 |
| Sep 20, 2021 | Neylan John F. | See Remarks | Sell | 376 | $10.07 | $3.8K | 36,241 |
| Sep 14, 2021 | Rhodes Jennifer J | See Remarks | Sell | 430 | $10.64 | $4.6K | 31,713 |
| Aug 18, 2021 | Neylan John F. | See Remarks | Sell | 381 | $9.03 | $3.4K | 36,617 |
| Aug 16, 2021 | Rhodes Jennifer J | See Remarks | Sell | 445 | $10.68 | $4.8K | 32,143 |
| Jul 21, 2021 | Neylan John F. | See Remarks | Sell | 365 | $10.98 | $4.0K | 36,998 |
| Jul 21, 2021 | Rhodes Jennifer J | See Remarks | Sell | 432 | $10.94 | $4.7K | 32,588 |
| Jul 14, 2021 | Rhodes Jennifer J | See Remarks | Sell | 431 | $11.01 | $4.7K | 32,589 |
| Jun 24, 2021 | Goldberg Itzhak | See Remarks | Sell | 197,410 | $6.50 | $1.28M1.1% OS | 2,020,068 |
| Jun 24, 2021 | Venkatesan Jay | See Remarks | Sell | 41,091 | $13.78 | $566.2K | 1,239,257 |
| Jun 18, 2021 | Neylan John F. | See Remarks | Sell | 366 | $13.20 | $4.8K | 37,363 |
| Jun 14, 2021 | Rhodes Jennifer J | See Remarks | Sell | 427 | $13.27 | $5.7K | 33,020 |
| May 18, 2021 | Neylan John F. | See Remarks | Sell | 363 | $13.91 | $5.0K | 37,729 |
| May 14, 2021 | Rhodes Jennifer J | See Remarks | Sell | 440 | $13.92 | $6.1K | 33,447 |
| Apr 19, 2021 | Neylan John F. | See Remarks | Sell | 381 | $13.55 | $5.2K | 38,092 |
| Apr 15, 2021 | Rhodes Jennifer J | See Remarks | Sell | 399 | $15.01 | $6.0K | 33,887 |
| Mar 17, 2021 | Neylan John F. | See Remarks | Sell | 442 | $19.13 | $8.5K | 38,453 |
| Mar 13, 2021 | Rhodes Jennifer J | See Remarks | Sell | 499 | $20.45 | $10.2K | 34,286 |
ELTX Insiders
Similar Stocks to ELTX
VRTX
Vertex Pharmaceuticals Incorporated
$476.29+0.08%
$126.50B
REGN
Regeneron Pharmaceuticals, Inc.
$662.73+1.01%
$68.29B
ALNY
Alnylam Pharmaceuticals, Inc.
$275.93-1.72%
$43.19B
RVMD
Revolution Medicines, Inc.
$185.71+0.42%
$40.34B
MRNA
Moderna, Inc.
$68.11+1.00%
$27.09B
INSM
Insmed Incorporated
$109.25-0.67%
$25.06B
INCY
Incyte Corporation
$114.43-0.30%
$23.32B
UTHR
United Therapeutics Corporation
$530.63+0.75%
$23.22B